Provided are a nonaqueous electrolyte capable of providing a nonaqueous electrolyte energy storage device with reduced direct current resistance and an increased capacity retention ratio after charge-discharge cycles, a nonaqueous electrolyte energy storage device including such a nonaqueous electrolyte, and a method for producing such a nonaqueous electrolyte energy storage device. One mode of the present invention is a nonaqueous electrolyte for an energy storage device, containing an additive represented by the following Formula (1) or Formula (2). In Formula (1), R.sup.1 to R.sup.4 are each independently a hydrogen atom or a group represented by —NR.sup.a.sub.2, —OR.sup.a, —SR.sup.a, etc., with the proviso that at least one of R.sup.1 to R.sup.4 is a group represented by —OR.sup.a, —SR.sup.a, —COOR.sup.a, —COR.sup.a, —SO.sub.2R.sup.a, or —SO.sub.3R.sup.a. In Formula (2), R.sup.5 to R.sup.7 are each independently a hydrogen atom or a group represented by —NR.sup.b.sub.2, —OR.sup.b, or —SR.sup.b, with the proviso that at least one of R.sup.5 to R.sup.7 is a group represented by —SR.sup.b.

##STR00001##

The present invention provides hTERT modulators and methods for producing and using the same. In particular, the present invention provide a compound of the formula:

##STR00001##

whereas, n, R.sup.1, R.sup.2, R.sup.3, R.sup.H and R.sup.12 are as defined herein.

The present invention provides hTERT modulators and methods for producing and using the same. In particular, the present invention provide a compound of the formula:

##STR00001##

whereas, n, R.sup.1, R.sup.2, R.sup.3, R.sup.H and R.sup.12 are as defined herein.

The present invention relates to a process for the preparation of strobilurin of compounds of Formula (I) of and its inter-mediates using 1,5,7-triazabicyclo[4.4.0]dec-5-ene or salts thereof, or derivatives thereof as a catalyst. The present invention provides the compounds of formula (I) in high yield and high purity.

The present invention relates to a process for the preparation of strobilurin of compounds of Formula (I) of and its inter-mediates using 1,5,7-triazabicyclo[4.4.0]dec-5-ene or salts thereof, or derivatives thereof as a catalyst. The present invention provides the compounds of formula (I) in high yield and high purity.

The invention relates to compositions and methods for inhibiting Krüppel-like Factor 10 (KLF10) for modulation of T regulatory cells and cancer immunotherapy.

The invention relates to compositions and methods for inhibiting Krüppel-like Factor 10 (KLF10) for modulation of T regulatory cells and cancer immunotherapy.

The present invention relates to a process for preparation of strobilurin compound, azoxystrobin and its intermediates using a catalyst selected from 1,8-Diazabicyclo[5.4.0]undec-7-ene or 1,5-Diazabicyclo[4.3.0]non-5-ene, salts thereof, or derivatives thereof.

The present invention relates to a process for preparation of strobilurin compound, azoxystrobin and its intermediates using a catalyst selected from 1,8-Diazabicyclo[5.4.0]undec-7-ene or 1,5-Diazabicyclo[4.3.0]non-5-ene, salts thereof, or derivatives thereof.

The present disclosure is concerned with 2-pyrimidone compounds that are capable of inhibiting a viral infection and methods of treating alphavirus viral infections such as, for example, chikungunya, Eastern equine encephalitis (EEEV), Western equine encephalitis (WEEV), and Venezuelan equine encephalitis using these compounds. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.